Leo Lens Technology
Harness the power of digital printing to turn contact lenses into drug delivery systems for the non-invasive treatment of diseases such as glaucoma and dry eye.
- Stage Prototype Ready
- Industry Biotechnology
- Location San Diego, CA, USA
- Currency USD
- Founded January 2001
- Employees 1
- Incorporation Type S-corp
- Website leolens.com
Company Summary
Leo Lens has a platform technology that harnesses the power of digital printing to turn FDA approved contact lenses into sustained delivery systems for therapeutics treating ocular diseases. Noncompliance with eye drops leads MILLIONS to suffer from disease progression and THOUSANDS to suffer from preventable blindness. There is a large unmet need for a better non-invasive treatment option. Leo Lens is driven to provide that option to patients.
Team
-
COO, General Counsel -
Founder / CEO40+ years of contact lens industry experience with multiple patents to his name and previous experience gaining FDA approval for devices
Advisors
-
David FancherUnconfirmed
Martin WatersUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.